For many pregnant women, medication decisions can be overwhelming. This is especially true when the drug is linked to mental health, and even more so when the Internet is filled with alarming headlines about pregnancy, autism, ADHD, and long-term child development.
A new study published in The Lancet Psychiatry may help bring some clarity to this discussion.
The researchers found that current evidence does not support a clear causal link between the use of the most common antidepressants during pregnancy and an increased risk of autism or ADHD in children. The findings come from a large systematic review and meta-analysis that pooled data from 37 studies, including more than 648,000 pregnancies exposed to antidepressants and nearly 25 million pregnancies without antidepressant exposure.
The point is not that every medication decision is simple. It’s just that the story seems to be a lot more complicated than “antidepressants cause autism” or “antidepressants cause ADHD.” And for parents trying to make careful decisions during pregnancy, this distinction matters.
The researchers looked at whether antidepressant use before or during pregnancy was associated with neurodevelopmental disorders in children, including autism spectrum disorder and attention-deficit/hyperactivity disorder, or ADHD.
At first glance, the data showed little correlation. Before the researchers adjusted for other factors, antidepressant use during pregnancy was associated with a higher observed risk of ADHD and autism in children. Specifically, the analysis found a 35% increased risk of ADHD and a 69% increased risk of autism before major confounders were taken into account.
But this is where the study becomes important.
When the researchers adjusted for things like parental mental health, family history, genetics and other shared family factors, this apparent link became much weaker or disappeared altogether. The authors also found similar patterns when they looked at antidepressant use before conception and, notably, fathers’ use of antidepressants during pregnancy. Since the father’s use of antidepressants during pregnancy would not expose the fetus to the medication in utero, this helped the researchers point to family and genetic factors rather than the medication itself.
This is a key point for parents: an association in a study does not always mean that one causes the other.
This topic has been studied in the past, but previous research has often been difficult to interpret. Pregnant women taking antidepressants are more likely to have depression, anxiety or other mental health conditions. These conditions may also have genetic and environmental associations with neurodevelopmental differences in children.
In other words, if researchers are simply comparing children whose mothers took antidepressants with children whose mothers did not, the comparison may not be fair. The two groups may differ significantly before medication is even considered.
This is called confusion by indication. It means that the reason someone takes a drug may be part of what explains the effect being studied.
Experts responding to the study said this was one of its strengths. The research used several approaches to test whether the drug itself was possibly responsible, including comparisons of maternal use before pregnancy, paternal use during pregnancy, and analyzes that attempted to account for familial and genetic factors.
What about SSRIs?
Many pregnant women taking antidepressants are prescribed selective serotonin reuptake inhibitors, or SSRIs. These are among the most commonly used antidepressants.
The study found that when analyzes were restricted to mothers with mental health disorders, SSRIs were not significantly associated with autism or ADHD. The study also found no clear difference in autism risk between high-dose and low-dose exposure, further weakening the argument that the drug itself was driving the association.
There was one area where researchers called for more attention. Amitriptyline and nortriptyline, older antidepressants often used as second- or third-line treatments, remained associated with an increased risk of ADHD or autism in some analyses. However, the authors noted that these drugs may be prescribed to people with more severe, chronic or complex mental health needs, which could affect the findings.
Mental Health in Pregnancy Issues
One of the most important parts of this study is that it does not treat medication as the only risk worth discussing.
Stopping antidepressants during pregnancy can also carry risks, particularly for people with moderate to severe depression. The Lancet press release notes that doctors and patients should weigh the potential risks of medication against the potential harms of a relapse of depression or an untreated mental illness.
This context is important because pregnant women often feel that the safest option is always to stop taking medication. But for many families, the safest option may be to continue treatment under medical supervision.
Mental health during pregnancy is not separate from physical health. It can affect sleep, nutrition, prenatal care, relationships, bonding and the overall stability a parent needs during a physically and emotionally demanding time. The study authors also emphasized that supporting both maternal and paternal mental health can benefit children’s long-term development.
This study does not mean that every antidepressant is suitable for every person during pregnancy. It also does not mean that decisions about taking medication should be made without a doctor.
What it does offer is reassurance: the best available evidence does not support the idea that common antidepressants used during pregnancy directly cause autism or ADHD.
For someone who is pregnant, planning a pregnancy, or taking antidepressants and feeling anxious, the practical next step is not to suddenly stop medication. It’s having a conversation with a health care provider who understands his history, symptoms, dosage, and overall health.
Pregnancy already comes with enough pressure. Parents deserve clear information, not fear-based messages. This study helps the debate in that direction, showing that the relationship between antidepressants, mental health, genetics and child development is complex – and that common antidepressants themselves do not appear to be the simple cause that some headlines suggest.
SOURCETIS
